MTD
Price
$1437.75
Change
+$56.31 (+4.08%)
Updated
Oct 23 closing price
Capitalization
28.46B
13 days until earnings call
Intraday Buy/Sell Signals
TMO
Price
$571.91
Change
+$4.71 (+0.83%)
Updated
Oct 23 closing price
Capitalization
214.18B
103 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MTD vs TMO

Header iconMTD vs TMO Comparison
Open Charts MTD vs TMOBanner chart's image
Mettler-Toledo International
Price$1437.75
Change+$56.31 (+4.08%)
Volume$146.72K
Capitalization28.46B
Thermo Fisher Scientific
Price$571.91
Change+$4.71 (+0.83%)
Volume$1.98M
Capitalization214.18B
MTD vs TMO Comparison Chart in %
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTD vs. TMO commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and TMO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (MTD: $1437.75 vs. TMO: $571.91)
Brand notoriety: MTD and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MTD: 107% vs. TMO: 91%
Market capitalization -- MTD: $28.46B vs. TMO: $214.18B
MTD [@Medical Specialties] is valued at $28.46B. TMO’s [@Medical Specialties] market capitalization is $214.18B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTD’s FA Score shows that 2 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • MTD’s FA Score: 2 green, 3 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, MTD is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTD’s TA Score shows that 5 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).

  • MTD’s TA Score: 5 bullish, 5 bearish.
  • TMO’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, TMO is a better buy in the short-term than MTD.

Price Growth

MTD (@Medical Specialties) experienced а +5.75% price change this week, while TMO (@Medical Specialties) price change was +6.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.39%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +34.31%.

Reported Earning Dates

MTD is expected to report earnings on Nov 06, 2025.

TMO is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Medical Specialties (+2.39% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($214B) has a higher market cap than MTD($28.5B). MTD has higher P/E ratio than TMO: MTD (36.45) vs TMO (33.04). MTD YTD gains are higher at: 17.494 vs. TMO (10.240). TMO has higher annual earnings (EBITDA): 11.3B vs. MTD (1.22B). TMO has more cash in the bank: 1.12B vs. MTD (61.8M). MTD has less debt than TMO: MTD (2.18B) vs TMO (35.2B). TMO has higher revenues than MTD: TMO (43.2B) vs MTD (3.87B).
MTDTMOMTD / TMO
Capitalization28.5B214B13%
EBITDA1.22B11.3B11%
Gain YTD17.49410.240171%
P/E Ratio36.4533.04110%
Revenue3.87B43.2B9%
Total Cash61.8M1.12B6%
Total Debt2.18B35.2B6%
FUNDAMENTALS RATINGS
MTD vs TMO: Fundamental Ratings
MTD
TMO
OUTLOOK RATING
1..100
2124
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
5963
SMR RATING
1..100
358
PRICE GROWTH RATING
1..100
2242
P/E GROWTH RATING
1..100
5056
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (67) in the Medical Specialties industry is somewhat better than the same rating for MTD (100). This means that TMO’s stock grew somewhat faster than MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (59) in the Medical Specialties industry is in the same range as TMO (63). This means that MTD’s stock grew similarly to TMO’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for TMO (58). This means that MTD’s stock grew somewhat faster than TMO’s over the last 12 months.

MTD's Price Growth Rating (22) in the Medical Specialties industry is in the same range as TMO (42). This means that MTD’s stock grew similarly to TMO’s over the last 12 months.

MTD's P/E Growth Rating (50) in the Medical Specialties industry is in the same range as TMO (56). This means that MTD’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTDTMO
RSI
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 1 day ago
59%
Declines
ODDS (%)
Bearish Trend 15 days ago
62%
Bearish Trend 12 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ORCX38.581.89
+5.15%
Defiance Daily Target 2X Long ORCL ETF
ACES34.710.45
+1.31%
ALPS Clean Energy ETF
VWID33.850.18
+0.53%
Virtus WMC International Dividend ETF
QMAR32.350.08
+0.26%
FT Vest Nasdaq-100 Buffer ETF – Mar
IBDU23.54-0.01
-0.04%
iShares iBonds Dec 2029 Term Corp ETF

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
+0.83%
A - TMO
80%
Closely correlated
+1.09%
DHR - TMO
80%
Closely correlated
+2.12%
MTD - TMO
76%
Closely correlated
+4.08%
RVTY - TMO
76%
Closely correlated
+1.98%
BRKR - TMO
67%
Closely correlated
+1.95%
More